Literature DB >> 8789987

Cholesterol emboli may mimic systemic vasculitis.

D S Peat1, P W Mathieson.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8789987      PMCID： PMC2351926          DOI： 10.1136/bmj.313.7056.546

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies.

Authors:  C D Pusey; A J Rees; D J Evans; D K Peters; C M Lockwood
Journal:  Kidney Int       Date:  1991-10       Impact factor: 10.612

2.  Renal involvement in Churg-Strauss syndrome.

Authors:  E J Clutterbuck; D J Evans; C D Pusey
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

3.  Eosinophilia as a clue to the diagnosis of atheroembolic renal disease.

Authors:  B S Kasinath; E J Lewis
Journal:  Arch Intern Med       Date:  1987-08

4.  Multiple cholesterol emboli syndrome simulating systemic necrotizing vasculitis.

Authors:  D K Young; M F Burton; J H Herman
Journal:  J Rheumatol       Date:  1986-04       Impact factor: 4.666

5.  c-ANCA as a marker of Wegener's disease.

Authors:  D J Unsworth; C R Tomson; R J Lock; T B Wallington; T G Feest
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

Review 6.  The clinical relevance of ANCA in vasculitis.

Authors:  W L Gross; S Hauschild; N Mistry
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  Necrotising glomerulonephritis associated with cholesterol microemboli.

Authors:  M Goldman; Y Thoua; M Dhaene; C Toussaint
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

8.  Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate.

Authors:  M Colombo; P M Mannucci; V Carnelli; G F Savidge; C Gazengel; K Schimpf
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

9.  The clinical spectrum of renal cholesterol embolization.

Authors:  M C Smith; M K Ghose; A R Henry
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

10.  Warfarin-related purple toes syndrome and cholesterol microembolization.

Authors:  B T Hyman; S K Landas; R F Ashman; R L Schelper; R A Robinson
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965
View more
  7 in total

1.  A 59 year old man with progressive spinal cord and peripheral nerve dysfunction culminating in encephalopathy: Edinburgh advanced clinical neurology course, 1999.

Authors:  R Al-Shahi; C P Warlow; G H Jansen; C J Frijns; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

2.  Cholesterol emboli syndrome--uncommon or unrecognized?

Authors:  S P Bell; A Frankel; E A Brown
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

3.  A man with purple toes.

Authors:  S Zaman; J Mallya; M Thomas
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

4.  Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases.

Authors:  A E Yücel; H Kart-Köseoglu; B Demirhan; F N Ozdemir
Journal:  Rheumatol Int       Date:  2005-07-16       Impact factor: 2.631

Review 5.  Pseudovasculitis: mechanisms of vascular injury and clinical spectrum.

Authors:  Rafael Grau
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.686

6.  Left Atrial Myxoma Mimicking Polyarteritis Nodosa.

Authors:  Gokhan Sargin; Taskin Senturk
Journal:  Yonsei Med J       Date:  2015-07       Impact factor: 2.759

7.  Anti-neutrophil cytoplasmic antibodies in cholesterol embolism: A case report and literature review.

Authors:  Jun Zhang; Heng-Yuan Zhang; Shi-Zhi Chen; Ji-Yi Huang
Journal:  Exp Ther Med       Date:  2016-05-17       Impact factor: 2.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.